Ovid Therapeutics (OVID) Stock Price, Quote, News & History | Benzinga

You can purchase shares of Ovid Therapeutics (NASDAQ:OVID) through any online brokerage.

View our list of the best stock brokerages

Other companies in Ovid Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).

Ovid Therapeutics has a consensus price target of $4.77.

The stock price for Ovid Therapeutics (NASDAQ: OVID) is $2.9 last updated November 9, 2026 at 8:33 AM EST.

There are no upcoming dividends for Ovid Therapeutics.

Ovid Therapeutics does not have any upcoming earnings scheduled.

There is no upcoming split for Ovid Therapeutics.

Ovid Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.